Rebecca Wray, Executive Director, Head of Strategy & Transformation – Late Development Oncology at AstraZeneca, shared on LinkedIn:
“I am very happy to share that I have been promoted to Executive Director, Head of Strategy and Transformation for Late Development Oncology at AstraZeneca.
Oncology is moving at extraordinary pace, and that makes the choices around where we focus, what we prioritise and how we evolve the way we work increasingly important.
My new remit brings together portfolio strategy, investment priorities, transformation and AI, shaping how we make those choices and how we use advances in science and technology to create greater impact for patients.
I feel incredibly fortunate to be taking this on, and grateful to the many people who have influenced my thinking and supported my growth, especially Leora Horn, for the trust, challenge and encouragement that have shaped how I lead.
I am excited to help shape what comes next, with one thing always in view: giving the best science the best possible chance of reaching patients.”
Other articles about AstraZeneca on OncoDaily.